Shogo Tsujikawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shogo Tsujikawa has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Takashi Mori
From the Department of Anesthesiology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
2 shared publications- Aashutosh Shetti
Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States. Dr. Tsujikawa is now with Department of Anesthesiology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
1 shared publication - Michaela M. Novakovic
Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States. Dr. Tsujikawa is now with Department of Anesthesiology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
1 shared publication - Murali Prakriya
Northwestern University, Feinberg School of Medicine
1 shared publication - Rogan A. Grant
Division of Pulmonary and Critical Care, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States
1 shared publication Ryota Watanabe
From the Department of Anesthesiology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
1 shared publication
Latest Publications
- 27 October 2026
- Published by Wolters Kluwer Health in Pain
- Vol. 167 (12) , 2846-2859
Astrocyte Orai1 signaling promotes spinal excitatory synaptic potentiation and neuropathic pain after nerve injury in male mice
Neuropathic pain after peripheral nerve injury is a multifactorial condition mediated partly by inflammation in the spinal cord that results in potentiation of excitatory synaptic transmission in nociceptive circuits. Glial cells including astrocytes are key mediators of the underlying inflammation, but the signaling checkpoints that regulate astrocyte-driven spinal cord inflammation and sensitization of nociceptive circuits are not well understood. Here, we identify Orai1-mediated store-operated Ca 2+ entry (SOCE) as an important regulator of spinal astrocyte cytokine production, metabolic reprogramming, and pain hypersensitivity in mice. Conditional deletion of Orai1 in astrocytes attenuated mechanical allodynia after nerve injury in male but not female mice, despite comparable SOCE suppression in both sexes. Orai1 deficiency also attenuated production of proinflammatory cytokines after SOCE activation, including TNFα, IL-6, and IL-33, both in vivo and in vitro. Electrophysiological recordings revealed that astrocyte Orai1 deletion prevented injury-induced enhancement of glutamatergic synaptic transmission in dorsal horn neurons, linking astrocytic Ca 2+ signaling to central sensitization. Metabolomic profiling showed that Orai1 loss disrupted glycolysis and TCA cycle intermediates while promoting accumulation of immunomodulatory metabolites such as itaconate, consistent with a less inflammatory astrocyte metabolic state. These findings identify Orai1 channels as integrators of astrocyte Ca 2+ signaling, immunometabolism, and excitatory synaptic potentiation after nerve injury, and identify a sexually dimorphic astrocyte mechanism governing neuropathic pain pathogenesis. Targeting astrocyte Orai1 channels may provide a selective therapeutic strategy for male-predominant chronic pain.
- 27 October 2026
- Published by Wolters Kluwer Health in Pain
- Vol. 167 (12) , 2846-2859
Astrocyte Orai1 signaling promotes spinal excitatory synaptic potentiation and neuropathic pain after nerve injury in male mice
Neuropathic pain after peripheral nerve injury is a multifactorial condition mediated partly by inflammation in the spinal cord that results in potentiation of excitatory synaptic transmission in nociceptive circuits. Glial cells including astrocytes are key mediators of the underlying inflammation, but the signaling checkpoints that regulate astrocyte-driven spinal cord inflammation and sensitization of nociceptive circuits are not well understood. Here, we identify Orai1-mediated store-operated Ca 2+ entry (SOCE) as an important regulator of spinal astrocyte cytokine production, metabolic reprogramming, and pain hypersensitivity in mice. Conditional deletion of Orai1 in astrocytes attenuated mechanical allodynia after nerve injury in male but not female mice, despite comparable SOCE suppression in both sexes. Orai1 deficiency also attenuated production of proinflammatory cytokines after SOCE activation, including TNFα, IL-6, and IL-33, both in vivo and in vitro. Electrophysiological recordings revealed that astrocyte Orai1 deletion prevented injury-induced enhancement of glutamatergic synaptic transmission in dorsal horn neurons, linking astrocytic Ca 2+ signaling to central sensitization. Metabolomic profiling showed that Orai1 loss disrupted glycolysis and TCA cycle intermediates while promoting accumulation of immunomodulatory metabolites such as itaconate, consistent with a less inflammatory astrocyte metabolic state. These findings identify Orai1 channels as integrators of astrocyte Ca 2+ signaling, immunometabolism, and excitatory synaptic potentiation after nerve injury, and identify a sexually dimorphic astrocyte mechanism governing neuropathic pain pathogenesis. Targeting astrocyte Orai1 channels may provide a selective therapeutic strategy for male-predominant chronic pain.
- Open Access
- 7 August 2026
- Published by Wolters Kluwer Health in A&A Practice
- Vol. 20 (8) , e02262
Spinal Epidural Abscess During a Spinal Cord Stimulation Trial in Complete Spinal Cord Injury: A Case Report
Chronic pain after spinal cord injury (SCI) is often refractory to medication, and spinal cord stimulation (SCS) may provide relief. We report a 48-year-old man with complete thoracic SCI who underwent an SCS trial for severe bilateral lower-extremity-pain. Although pain improved, low-grade fever, elevated inflammatory markers, and purulent drainage developed on day 7. Magnetic resonance imaging revealed a spinal epidural abscess (SEA). SCS leads were removed, and cultures grew methicillin-resistant Staphylococcus aureus . As the abscess was small without significant compression, conservative treatment with vancomycin was successful. This case highlights the diagnostic difficulty of SEA in complete SCI.
- 7 August 2026
- Published by Wolters Kluwer Health in A&A Practice
- Vol. 20 (8) , e02262
Open AccessSpinal Epidural Abscess During a Spinal Cord Stimulation Trial in Complete Spinal Cord Injury: A Case Report
Chronic pain after spinal cord injury (SCI) is often refractory to medication, and spinal cord stimulation (SCS) may provide relief. We report a 48-year-old man with complete thoracic SCI who underwent an SCS trial for severe bilateral lower-extremity-pain. Although pain improved, low-grade fever, elevated inflammatory markers, and purulent drainage developed on day 7. Magnetic resonance imaging revealed a spinal epidural abscess (SEA). SCS leads were removed, and cultures grew methicillin-resistant Staphylococcus aureus . As the abscess was small without significant compression, conservative treatment with vancomycin was successful. This case highlights the diagnostic difficulty of SEA in complete SCI.
- Open Access
- 10 April 2026
- Published by Wolters Kluwer Health in A&A Practice
- Vol. 20 (4) , e02195
Pecto-Intercostal Fascial Plane Radiofrequency Ablation for Chronic Post-Sternotomy Pain: A Case Report
Chronic post-sternotomy pain is a clinical problem that can impair quality of life. We report a case of refractory chest pain after coronary artery bypass grafting that was successfully treated using pecto-intercostal fascial plane radiofrequency ablation (PIFP-RFA). A 72-year-old man presented with persistent anterior chest pain that was unresponsive to medication for 1 year. Diagnostic PIFP blocks produced temporary complete pain relief, prompting the decision to perform RFA. Ultrasound-guided PIFP-RFA at the third and fourth parasternal intercostal levels bilaterally achieved complete pain resolution. This case highlights the safety and potential long-term efficacy of PIFP-RFA in patients receiving antithrombotic therapy.
- 10 April 2026
- Published by Wolters Kluwer Health in A&A Practice
- Vol. 20 (4) , e02195
Open AccessPecto-Intercostal Fascial Plane Radiofrequency Ablation for Chronic Post-Sternotomy Pain: A Case Report
Chronic post-sternotomy pain is a clinical problem that can impair quality of life. We report a case of refractory chest pain after coronary artery bypass grafting that was successfully treated using pecto-intercostal fascial plane radiofrequency ablation (PIFP-RFA). A 72-year-old man presented with persistent anterior chest pain that was unresponsive to medication for 1 year. Diagnostic PIFP blocks produced temporary complete pain relief, prompting the decision to perform RFA. Ultrasound-guided PIFP-RFA at the third and fourth parasternal intercostal levels bilaterally achieved complete pain resolution. This case highlights the safety and potential long-term efficacy of PIFP-RFA in patients receiving antithrombotic therapy.